TVM Life Science Innovation II SCSp — Form D/A
TVM Life Science Innovation II SCSp of Senningerberg, N4, a pooled investment fund, filed a Form D amendment with the SEC on 2020-10-19. The offering totals $368.9M, of which $368.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-10-19
- Form: D/A
- Accession: 0001767198-20-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $368.9M
- Amount sold: $368.9M
- Minimum investment: $250K
- Investors: 276
- Date of first sale: 2018-12-17
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-332471
Issuer
- Name: TVM Life Science Innovation II SCSp
- CIK: 0001767198
- Entity type: Limited Partnership
- Jurisdiction: LUXEMBOURG
- Incorporated: 2018
- Address: 8, RUE LOU HEMMER, Senningerberg, N4, L-1748
- Phone: 352 246 160 6152
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| N/A TVM Life Science Innovation II (GP) S.a.r.l. | Executive Officer | Senningerberg, N4 |
| N/A TVM Life Science Management, Inc. | Executive Officer | Westmount, A8 |
| N/A TVM Life Science Ventures VIII (GP) S.a.r.l. | Executive Officer | Luxembourg-Findel, 1Q |
Other filings by this issuer (1)
More